Nisa Investment Advisors LLC Purchases 600 Shares of Stericycle, Inc. (NASDAQ:SRCL)

Nisa Investment Advisors LLC increased its position in shares of Stericycle, Inc. (NASDAQ:SRCL) by 9.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,269 shares of the business services provider’s stock after purchasing an additional 600 shares during the period. Nisa Investment Advisors LLC’s holdings in Stericycle were worth $360,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of SRCL. Barclays PLC grew its position in Stericycle by 30.6% in the third quarter. Barclays PLC now owns 70,408 shares of the business services provider’s stock valued at $3,147,000 after acquiring an additional 16,505 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of Stericycle by 17.3% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 18,078 shares of the business services provider’s stock worth $808,000 after purchasing an additional 2,671 shares during the last quarter. Earnest Partners LLC grew its holdings in shares of Stericycle by 6.6% during the third quarter. Earnest Partners LLC now owns 1,941,254 shares of the business services provider’s stock worth $86,793,000 after purchasing an additional 120,852 shares during the last quarter. Pathstone Family Office LLC bought a new stake in shares of Stericycle during the third quarter worth $230,000. Finally, BNP PARIBAS ASSET MANAGEMENT Holding S.A. grew its holdings in shares of Stericycle by 25.7% during the third quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 67,860 shares of the business services provider’s stock worth $3,034,000 after purchasing an additional 13,860 shares during the last quarter. 98.82% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts have recently commented on SRCL shares. Stifel Nicolaus increased their target price on Stericycle from $70.00 to $75.00 and gave the stock a “buy” rating in a report on Thursday, February 29th. StockNews.com cut Stericycle from a “buy” rating to a “hold” rating in a report on Tuesday, April 2nd. Truist Financial increased their target price on Stericycle from $50.00 to $57.00 and gave the stock a “hold” rating in a report on Thursday, February 29th. Royal Bank of Canada restated an “outperform” rating and set a $69.00 target price on shares of Stericycle in a report on Thursday, March 7th. Finally, Wells Fargo & Company upped their price target on Stericycle from $40.00 to $48.00 and gave the company an “underweight” rating in a research note on Friday, March 1st. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $62.25.

Stericycle Stock Up 0.3 %

Shares of Stericycle stock opened at $48.87 on Friday. The business’s 50 day simple moving average is $51.39 and its 200 day simple moving average is $47.91. Stericycle, Inc. has a 52-week low of $37.78 and a 52-week high of $57.06. The firm has a market cap of $4.53 billion, a PE ratio of -203.62, a P/E/G ratio of 2.65 and a beta of 1.09. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.94 and a current ratio of 0.94.

Stericycle (NASDAQ:SRCL) last announced its earnings results on Wednesday, February 28th. The business services provider reported $0.54 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.47 by $0.07. Stericycle had a positive return on equity of 7.06% and a negative net margin of 0.80%. The business had revenue of $652.00 million for the quarter, compared to analyst estimates of $657.99 million. During the same quarter last year, the firm earned $0.60 EPS. Stericycle’s revenue for the quarter was down 2.7% compared to the same quarter last year. On average, analysts predict that Stericycle, Inc. will post 2.31 earnings per share for the current fiscal year.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.